医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Crosstalk between CYP2E1 and PPARα substrates and agonists modulate adipose browning and obesity

摘要Although the functions of metabolic enzymes and nuclear receptors in controlling physiological homeostasis have been established,their crosstalk in modulating metabolic disease has not been explored.Genetic ablation of the xenobiotic-metabolizing cytochrome P450 enzyme CYP2E1 in mice markedly induced adipose browning and increased energy expenditure to improve obesity.CYP2El deficiency acti-vated the expression of hepatic peroxisome proliferator-activated receptor alpha(PPARa)target genes,including fibroblast growth factor(FGF)21,that upon release from the liver,enhanced adipose browning and energy expenditure to decrease obesity.Nineteen metabolites were increased in Cyp2el-null mice as re-vealed by global untargeted metabolomics,among which four compounds,lysophosphatidylcholine and three polyunsaturated fatty acids were found to be directly metabolized by CYP2El and to serve as PPARαagonists,thus explaining how CYP2El deficiency causes hepatic PPARα activation through increasing cellular levels of endogenous PPARα agonists.Translationally,a CYP2E1 inhibitor was found to activate the PPARα-FGF21-beige adipose axis and decrease obesity in wild-type mice,but not in liver-specific Ppara-null mice.The present results establish a metabolic crosstalk between PPARα and CYP2E1 that supports the potential for a novel anti-obesity strategy of activating adipose tissue browning by targeting the CYP2E1 to modulate endogenous metabolites beyond its canonical role in xenobiotic-metabolism.

更多
广告
作者 Youbo Zhang [1] Tingting Yan [2] Tianxia Wang [3] Xiaoyan Liu [4] Keisuke Hamada [2] Dongxue Sun [2] Yizheng Sun [4] Yanfang Yang [4] Jing Wang [4] Shogo Takahashi [2] Qiong Wang [2] Kristopher W.Krausz [2] Changtao Jiang [5] Cen Xie [2] Xiuwei Yang [4] Frank J.Gonzalez [2] 学术成果认领
作者单位 State Key Laboratory of Natural and Biomimetic Drugs and Department of Natural Medicines,School of Pharmaceutical Sciences,Peking University,Beijing 100191,China;Laboratory of Metabolism,Center for Cancer Research,National Cancer Institute,National Institutes of Health,Bethesda,MD 20892,USA [1] Laboratory of Metabolism,Center for Cancer Research,National Cancer Institute,National Institutes of Health,Bethesda,MD 20892,USA [2] State Key Laboratory of Natural and Biomimetic Drugs and Department of Natural Medicines,School of Pharmaceutical Sciences,Peking University,Beijing 100191,China;School of Life Science and Engineering,Lanzhou University of Technology,Lanzhou 730050,China [3] State Key Laboratory of Natural and Biomimetic Drugs and Department of Natural Medicines,School of Pharmaceutical Sciences,Peking University,Beijing 100191,China [4] Department of Physiology and Pathophysiology,School of Basic Medical Sciences,Peking University,the Key Laboratory of Molecular Cardiovascular Science,Ministry of Education,Beijing 100191,China [5]
栏目名称
发布时间 2022-07-18(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览3
  • 下载0
药学学报(英文版)

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷